JW Pharmaceutical Corporation (KRX: 001060)
South Korea
· Delayed Price · Currency is KRW 24,250
+600 (2.54%)
Dec 18, 2024, 3:30 PM KST
JW Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 17, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 589,095 | 828,523 | 419,688 | 505,678 | 753,056 | 616,431 | Upgrade
|
| Market Cap Growth | -21.94% | 97.41% | -17.00% | -32.85% | 22.16% | -24.74% | Upgrade
|
| Enterprise Value | 628,184 | 959,912 | 491,395 | 649,827 | 873,041 | 765,409 | Upgrade
|
| Last Close Price | 23550.00 | 35550.00 | 17792.57 | 21052.34 | 30980.57 | 25161.32 | Upgrade
|
| PE Ratio | 19.36 | 22.71 | 13.16 | - | - | - | Upgrade
|
| Forward PE | 6.38 | 26.79 | 26.79 | 26.79 | 26.79 | 26.79 | Upgrade
|
| PS Ratio | 1.83 | 1.11 | 0.61 | 0.83 | 1.38 | 1.21 | Upgrade
|
| PB Ratio | 1.81 | 3.12 | 1.86 | 2.68 | 3.63 | 2.68 | Upgrade
|
| P/TBV Ratio | 2.35 | 3.29 | 1.84 | 2.68 | 3.86 | 2.87 | Upgrade
|
| P/FCF Ratio | 6.71 | 13.84 | 8.96 | 47.45 | 14.86 | 13.33 | Upgrade
|
| P/OCF Ratio | 7.18 | 9.51 | 7.39 | 27.90 | 11.94 | 11.10 | Upgrade
|
| EV/Sales Ratio | 0.85 | 1.28 | 0.72 | 1.07 | 1.60 | 1.50 | Upgrade
|
| EV/EBITDA Ratio | 5.30 | 8.05 | 6.35 | 13.84 | 45.08 | 573.24 | Upgrade
|
| EV/EBIT Ratio | 6.34 | 9.93 | 8.12 | 21.07 | - | - | Upgrade
|
| EV/FCF Ratio | 7.27 | 16.03 | 10.49 | 60.98 | 17.23 | 16.55 | Upgrade
|
| Debt / Equity Ratio | 0.44 | 0.64 | 0.93 | 1.30 | 0.88 | 0.82 | Upgrade
|
| Debt / EBITDA Ratio | 1.16 | 1.43 | 2.71 | 5.22 | 9.41 | 140.45 | Upgrade
|
| Debt / FCF Ratio | 1.56 | 2.84 | 4.47 | 23.00 | 3.60 | 4.05 | Upgrade
|
| Asset Turnover | 1.13 | 1.18 | 1.09 | 1.03 | 0.98 | 0.88 | Upgrade
|
| Inventory Turnover | 3.51 | 3.79 | 3.70 | 3.65 | 3.86 | 3.65 | Upgrade
|
| Quick Ratio | 0.93 | 0.90 | 0.80 | 0.79 | 0.78 | 0.81 | Upgrade
|
| Current Ratio | 1.42 | 1.32 | 1.12 | 1.30 | 1.28 | 1.21 | Upgrade
|
| Return on Equity (ROE) | 26.78% | 15.65% | 14.41% | -0.73% | -6.98% | -10.31% | Upgrade
|
| Return on Assets (ROA) | 9.34% | 9.49% | 6.00% | 3.26% | -0.15% | -2.04% | Upgrade
|
| Return on Capital (ROIC) | 13.60% | 13.87% | 8.70% | 4.68% | -0.20% | -2.70% | Upgrade
|
| Earnings Yield | 5.16% | 4.47% | 7.60% | -0.19% | -2.02% | -4.10% | Upgrade
|
| FCF Yield | 14.91% | 7.23% | 11.16% | 2.11% | 6.73% | 7.50% | Upgrade
|
| Dividend Yield | 1.67% | 1.10% | - | - | - | - | Upgrade
|
| Payout Ratio | 13.17% | 23.82% | 23.05% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -804.72% | -0.48% | -0.08% | 0.05% | -0.04% | 13.15% | Upgrade
|
| Total Shareholder Return | -803.05% | 0.62% | -0.08% | 0.05% | -0.04% | 13.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.